Clinical trials
Phase 1/2 Recurrence trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 10 |
| 2023 | 9 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 41 |
| Unknown status | 31 |
| Not yet recruiting | 6 |
| Completed | 5 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 8 |
| Chinese PLA General Hospital | 6 |
| Sun Yat-sen University | 6 |
| Han weidong | 3 |
| Huiqiang Huang | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| AstraZeneca | 2 |
| Beijing 302 Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 96 |
| Lymphoma, B-Cell | 10 |
| Leukemia, Myeloid, Acute | 8 |
| Lymphoma | 8 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, T-Cell, Peripheral | 7 |
| Multiple Myeloma | 7 |
| Burkitt Lymphoma | 5 |
| Hematologic Neoplasms | 5 |
| Lymphoma, Non-Hodgkin | 5 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.